ELI-002 7P

· Elicio Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ELI-002 7P, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors [Phase 1, Phase 2]